In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘TargetedTherapy’ clear

  • Dana-Farber researchers, including Dr. Rameen Beroukhim, have identified DNA mutations that appear to drive about 15 percent of meningiomas, a finding that could lead to the first effective drug treatments for these brain tumors.

Tags: TargetedTherapy, BrainTumors

  • Dr. Bruce E. Johnson said researchers at Foundation Medicine in Cambridge, Mass., have been routinely testing for certain "alterations" in cancer cells to help target treatments and new technologies.

Tags: Genomics, TargetedTherapy

  • A new analysis led by Dr. Toni Choueiri suggests that treatment with three targeted cancer drugs may be linked to a slightly increased risk of death, a finding that physicians should consider when developing treatment plans for their patients.

Tags: TargetedTherapy

  • Dr. Charles Fuchs led a study of ramucirumab, the first targeted drug for advanced stomach cancer to secure FDA approval.

Tags: TargetedTherapy

  • Dr. Barrett Rollins explained how Dana-Farber will use a $10 million grant from Massachusetts Life Sciences Center to support cancer imaging research to further the development of targeted cancer therapies.

Tags: Grants, TargetedTherapy

  • MolecularMD has obtained patent rights to technology—jointly owned by researchers at Dana-Farber and the Broad Institute. MolecularMD said it is developing diagnostic assays for use in clinical trials exploring the efficacy of targeted therapies.

Tags: BasicResearch, TargetedTherapy, Genetics

  • Dr. Barrett Rollins commented in The Journal of the American Medical Association about how precision medicine has helped patients at Dana-Farber.

Tags: Genomics, TargetedTherapy

  • Dr. Pasi Jänne led a study that showed a drug shrank lung tumors in 61 percent of patients whose cancers had developed the T790-M resistance mutation. He also commented on personalized medicine for cancer patients.

Tags: LungCancer, TargetedTherapy

  • Dr. Pasi A. Jänne discusses a new study that demonstrates that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer.

Tags: LungCancer, TargetedTherapy, Genetics

  • Dr. Edward J. Benz, Jr., talked about research to develop treatments for cancer that are more efficient and less toxic, by specifically targeting tumors using genetic analysis.

     

Tags: BasicResearch, TargetedTherapy

Showing 1-10 of 11 items